Prime Highlights
- Miami Beach cements its status as a top global healthcare innovation hub via the WHX Xcelerate Competition.
- Wink Biotherapeutics wins the grand prize for its breakthrough RNA therapeutics platform.
Key Facts
- Six top healthcare and life sciences startups compete as finalists.
- Wink Biotherapeutics lands a sponsored WHX Dubai 2027 exhibition slot and a 30-day mentorship program.
Background
The City of Miami Beach strengthened its role in the global healthcare innovation ecosystem as Economic Development Director Steven Anthony served as a judge at the WHX Miami Xcelerate Startup Competition, held at the Miami Beach Convention Center.
Anthony joined a panel of healthcare and innovation leaders to evaluate six startup finalists presenting breakthrough healthcare solutions spanning biotechnology, digital health and life sciences. Judges scored each company on innovation, feasibility, presentation quality and its ability to field questions from the panel.
Warren D. Marcus, Ph.D., co-founder and chief executive officer of Wink Biotherapeutics, led his healthcare startup to the top prize for its pioneering RNA therapeutics platform. The technology uses precision-targeted RNA to advance potential treatments for Type 1 diabetes and solid tumors.
As grand prize winner, Wink Biotherapeutics secured a sponsored exhibition opportunity at WHX Dubai 2027, a complimentary exhibition stand at WHX Miami 2027, and a 30-day executive mentorship program tied to its healthcare innovation work.
WHX Miami drew healthcare entrepreneurs, investors, executives and industry experts from around the world. The event gave emerging healthcare and life sciences companies a global stage to showcase technologies aimed at improving patient care and advancing medicine’s future.
Through its participation in events like WHX Miami, the City’s Economic Development Department keeps building relationships with healthcare innovators and industry leaders.
Miami Beach is pushing to become a leading hub for entrepreneurship, investment and growth in the healthcare and life sciences sectors.
